Development of a novel plant expressed conjugate vaccine for HER2-positive breast cancer
Overexpression HER2/neu correlates with poor prognosis in many cancers, including breast cancer. HER2 -specific monoclonal antibodies including Herceptin® have had significant impact on breast cancer survival rates. However, there are a number of limitations with their use, including tumour recurren...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Southampton
2016
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.694530 |